Ws profiles of upregulated entities and (B) represents downregulated entities. The

Ws profiles of upregulated entities and (B) represents downregulated entities. The fold change values of these entities are given in Supplementary Table S2.(218 upregulated and 122 down regulated proteins). The altered levels of each of the identified proteins were based on at least two peptides with two reporter ions for each peptide. We have identified and quantified 84 proteins with 2 peptides, 73 with 3 peptides and remaining 183 proteins with 4 or more peptides. For averaging the quantities of the proteins, we used only unique peptides identifying a protein with variability of less than 40 in the peptide ratio. Subcellular classification of the 340 differentially expressed proteins using Gene Ontology information from Human Protein Reference Database (HPRD) revealed majority (53 ) of them as proteins known to be associated with the endoplasmic reticulum and plasma membrane (Fig. 1B). Supplementary Table S1 provides the list of these proteins along with their peptide information, quantitative levels, molecular or biological functions and cellular localizations. Comparison of 340 differentially expressed proteins with the differentially expressed transcript data (1.5 fold change) by Sun et al.11 and accessed using Oncomine data resource (www.oncomine.org) in DA tumors revealed a total of 195 proteins (57.4 ) to be common (Supplementary Table S2). Of these, 189 proteins showed positive correlation in expression supporting our Stattic clinical trials observations and the proteomic data. The comparative differential protein and transcript expression in fold changes are shown in Fig. 2. Changes at the chromosome levels such as mutations, copy number variations are important factors that may affect downstream events relevant to tumor development. We also mapped differentially expressed proteins to the chromosome 12 which is EPZ004777 site implicated in glial tumors23, and found that three of the over expressed proteins, CNPY2, MYL6, LIMA1, mapped to the regions on the chromosome that have been described as amplicons24,25.Scientific RepoRts | 6:26882 | DOI: 10.1038/srepwww.nature.com/scientificreports/This provides a rationale and biological basis for their overexpression and confirms mass spectrometry results. To further confirm the quantitative differences observed by iTRAQ analysis, verification of the expression levels of EGFR, BCAN, ENPP6 and HNRNPK was carried out using immunohistochemistry (IHC) in tissue microarrays with DA tumor tissue sections. EGFR is well known for its involvement in tumorigenesis in general, BCAN is a brain-specific protein involved in brain development, ENPP6 is a protein implicated in the development of myelin sheath and HNRNP K is an important protein involved in post transcriptional regulation of gene expression. EGFR and BCAN are found to be over expressed at both protein and transcript level whereas over expression of the other two was observed only at protein level and not supported at the transcript level. MS/MS spectra of the peptide of representative overexpressed proteins, BCAN, EGFR, ENPP6, and HNRNP K and the corresponding IHC images are given in Fig. 3. We found that EGFR protein was overexpressed in 85 of DAs and BCAN showed overexpression in 77 of DAs in consistence with earlier observations26,27. ENPP6 was observed to be overexpressed in 30 cases of DA, while HNRNPK showed strong overexpression in all the DA cases (Fig. 3, Supplementary Table S3).Altered processes, enriched pathways and key molecular entities. Ingenuity Pathway.Ws profiles of upregulated entities and (B) represents downregulated entities. The fold change values of these entities are given in Supplementary Table S2.(218 upregulated and 122 down regulated proteins). The altered levels of each of the identified proteins were based on at least two peptides with two reporter ions for each peptide. We have identified and quantified 84 proteins with 2 peptides, 73 with 3 peptides and remaining 183 proteins with 4 or more peptides. For averaging the quantities of the proteins, we used only unique peptides identifying a protein with variability of less than 40 in the peptide ratio. Subcellular classification of the 340 differentially expressed proteins using Gene Ontology information from Human Protein Reference Database (HPRD) revealed majority (53 ) of them as proteins known to be associated with the endoplasmic reticulum and plasma membrane (Fig. 1B). Supplementary Table S1 provides the list of these proteins along with their peptide information, quantitative levels, molecular or biological functions and cellular localizations. Comparison of 340 differentially expressed proteins with the differentially expressed transcript data (1.5 fold change) by Sun et al.11 and accessed using Oncomine data resource (www.oncomine.org) in DA tumors revealed a total of 195 proteins (57.4 ) to be common (Supplementary Table S2). Of these, 189 proteins showed positive correlation in expression supporting our observations and the proteomic data. The comparative differential protein and transcript expression in fold changes are shown in Fig. 2. Changes at the chromosome levels such as mutations, copy number variations are important factors that may affect downstream events relevant to tumor development. We also mapped differentially expressed proteins to the chromosome 12 which is implicated in glial tumors23, and found that three of the over expressed proteins, CNPY2, MYL6, LIMA1, mapped to the regions on the chromosome that have been described as amplicons24,25.Scientific RepoRts | 6:26882 | DOI: 10.1038/srepwww.nature.com/scientificreports/This provides a rationale and biological basis for their overexpression and confirms mass spectrometry results. To further confirm the quantitative differences observed by iTRAQ analysis, verification of the expression levels of EGFR, BCAN, ENPP6 and HNRNPK was carried out using immunohistochemistry (IHC) in tissue microarrays with DA tumor tissue sections. EGFR is well known for its involvement in tumorigenesis in general, BCAN is a brain-specific protein involved in brain development, ENPP6 is a protein implicated in the development of myelin sheath and HNRNP K is an important protein involved in post transcriptional regulation of gene expression. EGFR and BCAN are found to be over expressed at both protein and transcript level whereas over expression of the other two was observed only at protein level and not supported at the transcript level. MS/MS spectra of the peptide of representative overexpressed proteins, BCAN, EGFR, ENPP6, and HNRNP K and the corresponding IHC images are given in Fig. 3. We found that EGFR protein was overexpressed in 85 of DAs and BCAN showed overexpression in 77 of DAs in consistence with earlier observations26,27. ENPP6 was observed to be overexpressed in 30 cases of DA, while HNRNPK showed strong overexpression in all the DA cases (Fig. 3, Supplementary Table S3).Altered processes, enriched pathways and key molecular entities. Ingenuity Pathway.